• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Keros Therapeutics, Inc.

Keros Therapeutics, Inc.

Public
KROS
United States
SectorHealthcare
CountryUnited States
Market cap224.88M
A clinical-stage biopharmaceutical company developing targeted therapies for cancer and immunological diseases.

Where to buy Keros Therapeutics, Inc. (KROS)

KROS trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare